As of 2025-06-22, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (9.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.75 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -1395.3%.
The range of the Relative Valuation is (6.20) - (12.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 26.2x | 19.2x |
| Forward P/E multiples | 12.7x - 28.5x | 20.6x |
| Fair Price | (6.20) - (12.79) | (9.71) |
| Upside | -926.7% - -1805.4% | -1395.3% |
| Date | P/E |
| 2025-06-13 | -1.38 |
| 2025-06-12 | -1.43 |
| 2025-06-11 | -1.44 |
| 2025-06-10 | -1.44 |
| 2025-06-09 | -1.53 |
| 2025-06-06 | -1.57 |
| 2025-06-05 | -1.47 |
| 2025-06-04 | -1.35 |
| 2025-06-03 | -1.29 |
| 2025-06-02 | -1.27 |
| 2025-05-30 | -1.28 |
| 2025-05-29 | -1.35 |
| 2025-05-28 | -1.43 |
| 2025-05-27 | -1.41 |
| 2025-05-23 | -1.35 |
| 2025-05-22 | -1.35 |
| 2025-05-21 | -1.26 |
| 2025-05-20 | -1.17 |
| 2025-05-19 | -1.14 |
| 2025-05-16 | -1.10 |
| 2025-05-15 | -1.09 |
| 2025-05-14 | -1.09 |
| 2025-05-13 | -1.29 |
| 2025-05-12 | -1.38 |
| 2025-05-09 | -1.44 |
| 2025-05-08 | -1.41 |
| 2025-05-07 | -1.40 |
| 2025-05-06 | -1.34 |
| 2025-05-05 | -1.47 |
| 2025-05-02 | -1.39 |
| 2025-05-01 | -1.48 |
| 2025-04-30 | -1.50 |
| 2025-04-29 | -1.37 |
| 2025-04-28 | -1.41 |
| 2025-04-25 | -1.45 |
| 2025-04-24 | -1.44 |
| 2025-04-23 | -1.38 |
| 2025-04-22 | -1.31 |
| 2025-04-21 | -1.18 |
| 2025-04-17 | -1.04 |
| 2025-04-16 | -1.02 |
| 2025-04-15 | -1.05 |
| 2025-04-14 | -1.09 |
| 2025-04-11 | -1.05 |
| 2025-04-10 | -1.01 |
| 2025-04-09 | -1.01 |
| 2025-04-08 | -1.03 |
| 2025-04-07 | -1.06 |
| 2025-04-04 | -0.86 |
| 2025-04-03 | -0.91 |